Botulinum toxin A - Aquavit Pharmaceuticals
Alternative Names: Aquatox™; AqubotulinumtoxinA; AqubotulinumtoxinA with intradermal microinjector; Clostridium botulinum toxin type A - Aquavit; DTX-023; DTX-024Latest Information Update: 03 May 2023
Price :
$50 *
At a glance
- Originator Aquavit Pharmaceuticals
- Class Analgesics; Anti-inflammatories; Antiarrhythmics; Antidepressants; Antimigraines; Antipruritics; Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Eye disorder therapies; Foot disorder therapies; Muscle relaxants; Recombinant proteins; Skin disorder therapies; Urologics; Vascular disorder therapies
- Mechanism of Action Acetylcholine inhibitors; Glutamate antagonists; Membrane transport protein modulators; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase III Unspecified
- Preclinical Hyperhidrosis